Cutaneous Rhabdomyosarcoma May Mask Melanoma - Top-Institutions - MDSpire

Cutaneous Rhabdomyosarcoma May Mask Melanoma

Molecular and epigenetic profiling suggested most tumors in a rare cutaneous sarcoma cohort were better classified as transdifferentiated melanoma.

  • By

  • Andrea Surnit

  • April 28, 2026

  • 3 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Dermatopathology
    • Melanoma Research
    • Molecular Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Melanoma Research
    • Molecular Pathology
    • Immunotherapy

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Dermatopathology
    • Cutaneous Oncology
    • Molecular Diagnostics

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Dermatopathology
    • Molecular Oncology
    • Melanoma Research

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Dermatopathology
    • Cutaneous Oncology
    • Molecular Pathology

Original Source(s)

Cutaneous Rhabdomyosarcoma May Mask Melanoma

  • by Andrea Surnit

  • April 28, 2026

Related Content

Intestinal tuberculosis in a child: a case report

Digital Twin Model May Improve Alcohol Intake Reconstruction

Integrated biomarker framework supports evaluation of drinking scenarios in forensic settings

AI May Improve Breast Mitotic Scoring

Junior pathologists showed higher mitotic score accuracy and agreement with artificial intelligence assistance in a preliminary single-center reader study